Print Page   |   Sign In   |   Register
News & Press: National News

Expert panel recommends new shingles vaccine that gives increased protection

Thursday, October 26, 2017  
Share |

The Washington Post 

October 25, 2017 


A federal expert panel Wednesday recommended a new and more effective shingles vaccine to protect adults 50 and older from a painful rash that affects 1 in 3 people during their lifetime.

In a rare move, the Advisory Committee on Immunization Practices also recommended, by an 8-to-7 vote, that the new Shingrix vaccine be preferred over the existing Zostavax vaccine because it provides far greater protection and is expected to prevent significant disease, especially among the elderly. The Food and Drug Administration approved the new vaccine, made by GlaxoSmithKline PLC, on Friday.

Shingrix is the first new vaccine for shingles in a decade, and it's the first time the panel is recommending that adults between 50 and 59 be vaccinated — a group that numbers about 42 million Americans. The panel also recommended that anyone who previously was vaccinated with the Zostavax vaccine be revaccinated with the new vaccine — an estimated 20 million people...Click here for the full story. 

Community Search
Sign In

Latest News

AIM Corporate Alliance